Dilated Cardiomyopathy Clinical Trial
Official title:
Effects of Respiratory Muscles Training on Cardiopulmonary Parameters and Quality of Life in Patients With Dilated Cardiomyopathy
The aim of this study was to determine the effects of respiratory muscles training on
cardiopulmonary parameters and quality of life in patients with dilated cardiomyopathy (DCM).
It was a randomized control trial conducted on the calculated sample size of 22 patients
divided into 2 groups. Study was conducted at Shifa International Hospital Islamabad.
Clinically stable, diagnosed cases of DCM aged 30 to 60 years were included in the study.
Outcomes of study were ejection fraction, Left ventricular (LV) End systolic dimensions, LV
End diastolic dimension, lung volumes and capacities and quality of life. Data was analyzed
on Statistical Package for the Social Sciences (SPSS) version 21.
.
Dilated cardiomyopathy is the most common type of heart failure and primary source of heart
replacement globally. It is characterized by poor left ventricular function,enlargement of
left ventricle and systolic dysfunction. The underlying cause of DCM in adults is usually
coronary artery disease, but other causes include inflammatory heart disease, myocardial
toxins, and genetic defects; approximately 30% to 35% of patients are reported to have a
genetic form of dilated cardiomyopathy. Most common sign and symptoms of dilated
cardiomyopathy are ankle swelling, dyspnea, fatigue, elevated jugular venous pressure
elevated, pulmonary rales due to reduced cardiac function with low output and elevated intra
cardiac pressures. Other sign and symptoms chest pain due to reduced coronary blood flow,
palpitation, syncope and sudden cardiac death. There is reduced exercise tolerance with
fatigue and dyspnea, contributing to poor prognosis and quality of life.
Chronic heart failure (CHF) patients have limited capacity to exercise and have impairments
in breathing function.Respiratory muscle weakness is a part of the underlying cause for
exercise intolerance in patients with heart failure with reduced ejection fraction.
Pharmacological and non pharmacological management is directed to reduce clinical sign and
symptoms and control of disease progression and complications like sudden cardiac arrest.
Physical rehabilitation is beneficial, effective and safe for functional limitation of DCM
patients. A modified Bruce protocol is usually used to gradually increase exercise intensity
in cardiac rehabilitation programs for patients with cardiomyopathy. Bruce protocol was used
to observe fluctuations in heart rate through a quick increase of exercise intensity for a
short period of time. Some patients are able to exercise with higher intensity safely, but
many patients reported difficulties on treadmill exercise. This becomes even more difficult
when the intensity of the treadmill exercise is increased.
Various studies have demonstrated the effects of exercise as well as inspiratory muscle
training for improvement in patients with CHF and have considered it an important component
of cardiac rehabilitation. Respiratory muscles training is commonly performed using
inspiratory resistance devices but studies have proven that incentive spirometry could be an
interesting alternative for clinical use for the cases where there is difficult to acquire
the devices. Slow breathing treatment is safe and induces favourable effects in
cardiopulmonary parameters, decreases rate of dyspnea, improves exercise performance and
increases respiratory muscles and function. Deeper and slow breathing involves the use of
diaphragm that is activated during slow breathing and does not increase respiratory
workload.Respiratory muscles training is safe and improves physiologic parameters including
an increase in oxygen saturation and improved exercise capacity, leading to an improvement in
health status.
This study is intended to observed the overall effect of respiratory muscles training
including slow breathing and incentive spirometry along with treadmill training according to
bruce protocol for improvement in their ejection fraction, left ventricular dimensions ,
pulmonary function and quality of life.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|
||
Recruiting |
NCT04982081 -
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
|
Phase 1 | |
Not yet recruiting |
NCT04703751 -
Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents
|
N/A | |
Recruiting |
NCT01157299 -
Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO
|
N/A | |
Completed |
NCT00765518 -
Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
|
Phase 2 | |
Completed |
NCT02115581 -
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
|
Phase 4 | |
Recruiting |
NCT04246450 -
Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy
|
N/A | |
Recruiting |
NCT05799833 -
Low QRS Voltages in Young Healthy Individuals and Athletes
|
||
Recruiting |
NCT01914081 -
Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside
|
Phase 3 | |
Recruiting |
NCT03061994 -
Metabolomic Study of All-age Cardiomyopathy
|
N/A | |
Recruiting |
NCT02915718 -
A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
|
N/A | |
Completed |
NCT03893760 -
Assessment of Right Ventricular Function in Advanced Heart Failure
|
||
Not yet recruiting |
NCT01219452 -
Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
|
Phase 1/Phase 2 | |
Recruiting |
NCT02175836 -
Arrhythmia Prediction Trial
|
N/A | |
Active, not recruiting |
NCT00962364 -
Long-term Evaluation of Patients Receiving Bone Marrow-derived Cell Administration for Heart Disease
|
||
Recruiting |
NCT05026112 -
The Arrhythmogenic Potential of Midwall Septal Fibrosis in Dilated Cardiomyopathy
|
||
Recruiting |
NCT05237323 -
Micophenolate Mofetil Versus Azathioprine in Myocarditis
|
Phase 3 | |
Recruiting |
NCT04649034 -
Intraventricular Stasis In Cardiovascular Disease
|
||
Suspended |
NCT03071653 -
Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study
|
Phase 2 | |
Completed |
NCT02619825 -
Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)
|
N/A |